AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . October 7th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV/AIDS Therapy - Filgrastim may interfere with antiretroviral efficacy
HIV/AIDS Therapy - Key T-cell subset loses efficacy during structured treatment interruptions
HIV/AIDS Therapy - Interleukin-2 safe for patients with low HHV-8 viremia
HIV/AIDS Therapy - Once-daily quadruple regimen safe, effective
HIV/AIDS Therapy - Synthetic gp41 analogs inhibit feline virus function
Starvation - HIV/AIDS playing key role in worsening southern Africa's food crisis - U.N. envoy
AIDS Therapy - Board recommends to breaking code of Coviracil pivotal trial early
AIDS Therapy - New compliance technology, The Pill Timer, shows promise
Anemia - Campaign launched to help chronically ill patients
Appointments - 'Naked DNA Company' expands management team
Awards - Missing Chinese AIDS activist named winner of U.S.-Canadian health award
Diagnostics - License granted to Roche Diagnostics
Epidemiology - European Union reports 11% fall in new AIDS cases
Facilities - CDC to open office in Guyana to help fight HIV/AIDS
Finance - Immune-based therapy maker announces second quarter 2002 financial results
Finance - Lipid Sciences reports second-quarter results
Fungal Infection - SBIR grant renewed for development of oral Amphotericin B
HIV/AIDS Therapy - Product R clinical trial results subject of published study
Immune-based Therapies - Letter of intent for potential investment announced
Infectious Disease - PKIDs begins HIV and hepatitis prevention work in China
Policy - China denies plans to make AIDS drugs that violate foreign patents
Policy - U.S. to provide AIDS assistance to Vietnam
Risk Factors - Hispanic women on border face higher HIV risk
Sexually Transmitted Diseases - Arizona study shows many youth engage in unprotected sex
Substance Abuse - Health officials warn drugs can reignite surge of HIV
Transplantation Medicine - Transplants in HIV patients should proceed, but drug interactions a concern
Virology - Trinity announces Remune study results
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
